Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹787 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹787 Cr
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr
Mar2021₹-442 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹787 Cr
Positive
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr
Negative
Mar2021 ₹-442 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,176.1 Cr -0.3% 1.8% 34.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,541.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹163,031.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,451.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,377.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,355.5 Cr -2.8% -8.1% -11.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.3%

1.8%

34.3%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses